Hoth Therapeutics resumes ATM equity offering under existing H.C. Wainwright agreement

Hoth Therapeutics, Inc.

On April 16, 2026, Hoth filed a new prospectus supplement to resume sales of common stock under its ATM agreement with H.C. Wainwright.
The ATM offering was previously suspended on April 1, 2026, but the Sales Agreement remained in effect.
The new prospectus supplement relates to the company's existing effective S-3 registration statement (File No. 333-291566).
No specific terms (size, price, or expected proceeds) were disclosed in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.